On 6^th June 2013 the Norwegian Forskningsradet agreed to fund the next phase of rituximab trials of Professor Olav Mella and Dr Oystein Fluge from Haukeland University Hospital in Bergen [R1].

These trials have already been discussed by Professor Mella and Dr Fluge in the last three Invest in ME International ME Conferences, as well as the research meetings organised in collaboration by Invest in ME in collaboration with Alison Hunter Memorial Foundation of Australia.

Further Reading:

What is Happening with the Research into ME and Rituximab?

 ME RESEARCH in NORWAY - Update